Displaying drugs 11476 - 11500 of 12502 in total
L-methionine (R)-S-oxide
Experimental
Matched Iupac: … (2S)-2-amino-4-[(R)-methanesulfinyl]butanoic acid …
Tosyl-D-Proline
Experimental
Matched Iupac: … (2R)-1-(4-methylbenzenesulfonyl)pyrrolidine-2-carboxylic acid …
Thiarsa Dihydroxy Cysteine
Experimental
Matched Iupac: … (2R)-2-amino-3-[(dihydroxyarsanyl)sulfanyl]propanoic acid …
Eucalyptol
Eucalyptol is naturally produced cyclic ether and monoterpenoid. Eucalyptol is an ingredient in many brands of mouthwash and cough suppressant. It controls airway mucus hypersecretion and asthma via anti-inflammatory cytokine inhibition. Eucalyptol is an effective treatment for nonpurulent rhinosinusitis. Eucalyptol reduces inflammation and pain when applied topically. It kills leukaemia...
Experimental
Nutraceutical
Matched Iupac: … (1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane …
Indalpine
Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market.
Investigational
Withdrawn
Matched Iupac: … 3-[2-(piperidin-4-yl)ethyl]-1H-indole …
CP-39,332
CP-39,332 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It is part of a group of monoamine reuptake inhibitor stereoisomers including tametraline (1R,4S-), CP-24,442 (1S,4R-), CP-22,185 (cis-), and CP-22,186 that show varying efficiency. However, none of the members of this stereoisomers has been marketed.
Experimental
Matched Iupac: … N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine …
AZD-3043
AZD3043 has been used in trials studying the treatment and basic science of Safety, Sedation, Tolerability, and Pharmacokinetics.
Investigational
Matched Iupac: … propyl 2-{4-[(diethylcarbamoyl)methoxy]-3-ethoxyphenyl}acetate …
N-omega-nitro-L-arginine methyl ester
L-NAME has been investigated for the treatment of Hypotension and Spinal Cord Injury.
Investigational
Matched Iupac: … methyl (2S)-2-amino-5-(N'-nitrocarbamimidamido)pentanoate …
Phenglutarimide
Experimental
Matched Iupac: … 3-[2-(diethylamino)ethyl]-3-phenylpiperidine-2,6-dione …
Mecloxamine
Experimental
Matched Iupac: … {2-[1-(4-chlorophenyl)-1-phenylethoxy]propyl}dimethylamine …
Matched Salts cas: … 56050-03-4 …
Matched Salts cas: … 56050-03-4 …
Fencamfamin
Fencamfamin (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite suppressant, but was later withdrawn for this application due to problems with dependence and abuse. It is around half the potency of dexamphetamine, and is prescribed at a dose of 10-60mg, although abusers of the...
Experimental
Illicit
Withdrawn
Matched Iupac: … N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine …
Matched Salts cas: … 2240-14-4 …
Matched Salts cas: … 2240-14-4 …
Thiarsahydroxy-Cysteine
Experimental
Matched Iupac: … (2R)-2-amino-3-[(hydroxyarsanyl)sulfanyl]propanoic acid …
Inhibitor of P38 Kinase
Inhibitor of P38 Kinase is a solid. This compound belongs to the indoles. These are compounds containing an indole moiety, which consists of a pyrrole ring fused to benzene to form 2,3-benzopyrrole. This drug is known to target mitogen-activated protein kinase 14.
Experimental
Matched Iupac: … 3-[2-(pyridin-4-yl)ethyl]-1H-indole …
S-(Methylmercury)-L-Cysteine
Experimental
Matched Iupac: … (2S)-2-amino-3-[(methylmercurio)sulfanyl]propanoic acid …
Trifluoromethionine
Experimental
Matched Iupac: … (2S)-2-amino-4-[(trifluoromethyl)sulfanyl]butanoic acid …
Difluoromethionine
Experimental
Matched Iupac: … (2S)-2-amino-4-[(difluoromethyl)sulfanyl]butanoic acid …
S-(Dimethylarsenic)Cysteine
Experimental
Matched Iupac: … (2R)-2-amino-3-[(dimethylarsanyl)sulfanyl]propanoic acid …
Displaying drugs 11476 - 11500 of 12502 in total